本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

157.94
-0.3400-0.21%
盤後157.940.00000.00%19:52 EDT
成交量:26.50萬
成交額:4,202.08萬
市值:94.52億
市盈率:-23.36
高:161.91
開:158.47
低:157.01
收:158.28
資料載入中...
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/10

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/05

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/16

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/02

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]